Bartlett & Co. Wealth Management LLC Meridian Bioscience Inc Transaction History

Bartlett & Co. Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2024	SELL	$31.15 - $33.39 $89,182 - $95,595	-2,863 Closed	0 $0
Q2 2022 Feb 14, 2024	SELL	$23.75 - $31.69 $43,367 - $57,865	-1,826 Reduced 38.94%	2,863 $87.1 Million
Q3 2021 Feb 13, 2024	SELL	$17.35 - $22.5 $2,602 - $3,375	-150 Reduced 3.1%	4,689 $90.2 Million
Q1 2021 Feb 13, 2024	SELL	$19.76 - $29.89 $5,928 - $8,967	-300 Reduced 5.84%	4,839 $127 Million
Q3 2020 Feb 13, 2024	BUY	$13.54 - $26.41 $4,061 - $7,923	300 Added 6.2%	5,139 $87.3 Million
Q1 2018 Feb 13, 2024	BUY	$13.8 - $16.2 $66,778 - $78,391	4,839 New	4,839 $68.7 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.